Update: 05.08.2025
Last week: 30 week 2025 (21.07.2025 - 27.07.2025)
Last full month: June 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 446 | -10.6% | 13.7% | -0.8 | 17 387 369 | -10.5% | 10.4% | -0.6 | -5.5% |
| MoM | 37 233 | -7.6% | 13.8% | 0.7 | 85 829 713 | -6.9% | 10.4% | 0.5 | -12.2% |
| YTD | 268 871 | 23.9% | 13.1% | 1.6 | 597 168 465 | 27.1% | 9.8% | 0.3 | 8.3% |
| MAT | 473 237 | 25.8% | 13.2% | 2.7 | 966 292 807 | 22.0% | 9.5% | 0.7 | 0.3% |
| BRAINMAX | |||||||||
| WoW | 1 813 | -2.2% | 100.0% | 0 | 6 227 494 | -1.6% | 100.0% | 0 | -2.2% |
| MoM | 9 254 | -14.8% | 100.0% | 0 | 31 670 923 | -15.6% | 100.0% | 0 | -14.8% |
| YTD | 70 877 | 103.9% | 100.0% | 0 | 244 936 235 | 100.0% | 100.0% | 0 | 103.9% |
| MAT | 118 785 | 102.0% | 100.0% | 0 | 409 193 707 | 97.3% | 100.0% | 0 | 102.0% |
| GOLDLINE PLUS | |||||||||
| WoW | 12 620 | -6.5% | 46.9% | 0.7 | 41 503 916 | -6.2% | 38.1% | 0 | -7.9% |
| MoM | 66 580 | -9.1% | 45.3% | -0.4 | 215 110 389 | -7.2% | 36.8% | -0.1 | -8.4% |
| YTD | 476 362 | -6.7% | 45.8% | 0.9 | 1 537 349 883 | -4.5% | 37.4% | 0.7 | -8.5% |
| MAT | 794 746 | -6.4% | 46.0% | 0.5 | 2 529 635 429 | -5.8% | 37.6% | -0.4 | -7.4% |
| MIGRENIUM | |||||||||
| WoW | 7 253 | -7.7% | 0.3% | 0 | 2 589 434 | -7.4% | 0.4% | 0 | -4.5% |
| MoM | 35 334 | 1.6% | 0.4% | 0 | 12 508 012 | 1.7% | 0.5% | 0 | -2.4% |
| YTD | 243 051 | -31.1% | 0.4% | -0.2 | 85 527 382 | -21.3% | 0.5% | -0.2 | 5.6% |
| MAT | 457 930 | -26.4% | 0.4% | -0.1 | 158 511 973 | -3.2% | 0.5% | -0.1 | 1.6% |
| MODELAX-N | |||||||||
| WoW | 24 146 | -4.4% | 18.6% | -0.6 | 13 564 681 | -3.1% | 13.6% | -0.2 | -1.2% |
| MoM | 132 142 | 22.5% | 23.4% | 5.5 | 71 577 944 | 18.9% | 16.8% | 3.5 | -6.1% |
| YTD | 852 828 | -4.1% | 20.2% | -2.9 | 454 918 470 | 19.3% | 14.6% | -0.3 | 9.8% |
| MAT | 1 426 694 | 1.5% | 20.1% | -1.1 | 732 938 067 | 31.2% | 14.0% | 1.1 | 7.1% |
| REDUXIN | |||||||||
| WoW | 8 507 | -8.1% | 31.6% | 0 | 47 108 520 | -4.8% | 43.2% | 0.7 | -7.9% |
| MoM | 47 301 | -3.6% | 32.2% | 1.6 | 259 867 661 | -3.6% | 44.4% | 1.6 | -8.4% |
| YTD | 329 131 | -12.2% | 31.6% | -1.3 | 1 794 890 067 | -10.8% | 43.7% | -2.2 | -8.5% |
| MAT | 549 893 | -8.9% | 31.8% | -0.5 | 2 946 304 803 | -6.2% | 43.8% | -0.6 | -7.4% |
| REDUXIN FORTE | |||||||||
| WoW | 2 857 | -11.3% | 10.6% | -0.4 | 13 505 268 | -9.8% | 12.4% | -0.5 | -7.9% |
| MoM | 14 925 | -11.6% | 10.2% | -0.4 | 67 674 135 | -14.3% | 11.6% | -1 | -8.4% |
| YTD | 104 725 | 4.8% | 10.1% | 1.3 | 477 994 689 | 10.3% | 11.6% | 1.8 | -8.5% |
| MAT | 172 171 | 3.4% | 10.0% | 1 | 766 502 990 | 8.0% | 11.4% | 1.4 | -7.4% |
| SALVISAR | |||||||||
| WoW | 8 150 | -6.3% | 1.2% | 0 | 4 381 818 | -6.4% | 1.2% | 0 | -4.8% |
| MoM | 43 045 | -15.1% | 1.4% | -0.2 | 22 927 579 | -12.1% | 1.4% | -0.1 | -5.0% |
| YTD | 360 508 | 18.9% | 1.7% | 0.3 | 181 002 962 | 47.2% | 1.6% | 0.4 | -2.2% |
| MAT | 629 104 | 24.9% | 1.6% | 0.4 | 298 978 593 | 57.4% | 1.6% | 0.5 | -4.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 268 871 | 23.9% | 13.1% | 1.6 | 597 168 465 | 27.1% | 9.8% | 0.3 | 8.3% |
| BRAINMAX | 70 877 | 103.9% | 100.0% | 0 | 244 936 235 | 100.0% | 100.0% | 0 | 103.9% |
| GOLDLINE PLUS | 476 362 | -6.7% | 45.8% | 0.9 | 1 537 349 883 | -4.5% | 37.4% | 0.7 | -8.5% |
| MIGRENIUM | 243 051 | -31.1% | 0.4% | -0.2 | 85 527 382 | -21.3% | 0.5% | -0.2 | 5.6% |
| MODELAX-N | 852 828 | -4.1% | 20.2% | -2.9 | 454 918 470 | 19.3% | 14.6% | -0.3 | 9.8% |
| REDUXIN CAPS | 329 131 | -12.2% | 31.6% | -1.3 | 1 794 890 067 | -10.8% | 43.7% | -2.2 | -8.5% |
| REDUXIN FORTE | 104 725 | 4.8% | 10.1% | 1.3 | 477 994 689 | 10.3% | 11.6% | 1.8 | -8.5% |
| SALVISAR | 360 508 | 18.9% | 1.7% | 0.3 | 181 002 962 | 47.2% | 1.6% | 0.4 | -2.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 473 237 | 25.8% | 13.2% | 2.7 | 966 292 807 | 22.0% | 9.5% | 0.7 | 0.3% |
| BRAINMAX | 118 785 | 102.0% | 100.0% | 0 | 409 193 707 | 97.3% | 100.0% | 0 | 102.0% |
| GOLDLINE PLUS | 794 746 | -6.4% | 46.0% | 0.5 | 2 529 635 429 | -5.8% | 37.6% | -0.4 | -7.4% |
| MIGRENIUM | 457 930 | -26.4% | 0.4% | -0.1 | 158 511 973 | -3.2% | 0.5% | -0.1 | 1.6% |
| MODELAX-N | 1 426 694 | 1.5% | 20.1% | -1.1 | 732 938 067 | 31.2% | 14.0% | 1.1 | 7.1% |
| REDUXIN CAPS | 549 893 | -8.9% | 31.8% | -0.5 | 2 946 304 803 | -6.2% | 43.8% | -0.6 | -7.4% |
| REDUXIN FORTE | 172 171 | 3.4% | 10.0% | 1 | 766 502 990 | 8.0% | 11.4% | 1.4 | -7.4% |
| SALVISAR | 629 104 | 24.9% | 1.6% | 0.4 | 298 978 593 | 57.4% | 1.6% | 0.5 | -4.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 446 | -10.6% | 13.7% | -0.8 | 17 387 369 | -10.5% | 10.4% | -0.6 | -5.5% |
| BRAINMAX | 1 813 | -2.2% | 100.0% | 0 | 6 227 494 | -1.6% | 100.0% | 0 | -2.2% |
| GOLDLINE PLUS | 12 620 | -6.5% | 46.9% | 0.7 | 41 503 916 | -6.2% | 38.1% | 0 | -7.9% |
| MIGRENIUM | 7 253 | -7.7% | 0.3% | 0 | 2 589 434 | -7.4% | 0.4% | 0 | -4.5% |
| MODELAX-N | 24 146 | -4.4% | 18.6% | -0.6 | 13 564 681 | -3.1% | 13.6% | -0.2 | -1.2% |
| REDUXIN CAPS | 8 507 | -8.1% | 31.6% | 0 | 47 108 520 | -4.8% | 43.2% | 0.7 | -7.9% |
| REDUXIN FORTE | 2 857 | -11.3% | 10.6% | -0.4 | 13 505 268 | -9.8% | 12.4% | -0.5 | -7.9% |
| SALVISAR | 8 150 | -6.3% | 1.2% | 0 | 4 381 818 | -6.4% | 1.2% | 0 | -4.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 37 233 | -7.6% | 13.8% | 0.7 | 85 829 713 | -6.9% | 10.4% | 0.5 | -12.2% |
| BRAINMAX | 9 254 | -14.8% | 100.0% | 0 | 31 670 923 | -15.6% | 100.0% | 0 | -14.8% |
| GOLDLINE PLUS | 66 580 | -9.1% | 45.3% | -0.4 | 215 110 389 | -7.2% | 36.8% | -0.1 | -8.4% |
| MIGRENIUM | 35 334 | 1.6% | 0.4% | 0 | 12 508 012 | 1.7% | 0.5% | 0 | -2.4% |
| MODELAX-N | 132 142 | 22.5% | 23.4% | 5.5 | 71 577 944 | 18.9% | 16.8% | 3.5 | -6.1% |
| REDUXIN CAPS | 47 301 | -3.6% | 32.2% | 1.6 | 259 867 661 | -3.6% | 44.4% | 1.6 | -8.4% |
| REDUXIN FORTE | 14 925 | -11.6% | 10.2% | -0.4 | 67 674 135 | -14.3% | 11.6% | -1 | -8.4% |
| SALVISAR | 43 045 | -15.1% | 1.4% | -0.2 | 22 927 579 | -12.1% | 1.4% | -0.1 | -5.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs